We confirmed that tumor cells that had been preincubated with cetuximab showed similar binding to the anti-EGFR detection antibody (Supplementary Figure 1(b)), indicating that both anti-EGFR antibodies bind to different epitopes and therefore do not interfere with each other. The gene discussed is EGFR; the disease is neoplasm.